Login | New Member? Signup Free
ChangeDetect » News

Achievement of pre-clinical milestone triggers $4M payment from GSK to Epizyme

Epizyme, Inc., a company leading the discovery and development of personalized therapeutics for genetically-defined cancer patients, today announced the achievement of pre-clinical milestones in its alliance with GlaxoSmithKline , triggering $4 million in milestone payments.

Tags: , , , , ,